[1] |
Takeuchi H, Kitagawa Y. Circulating tumor cells in gastrointestinal cancer[J]. J Hepatobiliary Pancreat Sci, 2010, 17(5): 577-582.
|
[2] |
Deng Z, Wu S, Wang Y, et al. Circulating tumor cell isolation for cancer diagnosis and prognosis[J]. EBioMedicine, 2022, 83: 104237.
|
[3] |
Pereira-Veiga T, Schneegans S, Pantel K, et al. Circulating tumor cell-blood cell crosstalk: biology and clinical relevance[J]. Cell Rep, 2022, 40(9): 111298.
|
[4] |
Chen Y, Zhu M, Shen J, et al. Chemosensitivity evaluation using circulating tumor cells predicts chemotherapy outcomes in patients with advanced cancer[J]. Clin Lab, 2022, 68(1): 210218.
|
[5] |
寇晓霞, 郭玲玲, 仇金荣. 循环肿瘤细胞药物敏感性指导的化学治疗在晚期胆系肿瘤中的临床疗效[J]. 第二军医大学学报, 2021, 42(10): 1098-1106.
|
[6] |
Tretyakova MS, Menyailo ME, Schegoleva AA, et al. Technologies for viable circulating tumor cell isolation[J]. Int J Mol Sci, 2022, 23(24): 15979.
|
[7] |
Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies[J]. Nat Rev Clin Oncol, 2018, 15(2): 81-94.
|
[8] |
Kodera Y, Ito S, Fujiwara M, et al. In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues[J]. Int J Clin Oncol, 2006, 11(6): 449-453.
|
[9] |
Ranftl RE, Calvo F. Analysis of breast cancer cell invasion using an organotypic culture system[J]. Methods Mol Biol, 2017, 1612: 199-212.
|
[10] |
Okada S, Vaeteewoottacharn K, Kariya R. Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models[J]. Cells, 2019, 8(8): 889.
|
[11] |
Hsieh CH, Yeh CT, Huang YH, et al. Circulating tumor cells derived from advanced hepatocellular carcinoma rapidly develop resistance to cytotoxic chemotherapy[J]. Anticancer Res, 2022, 42(5): 2479-2486.
|
[12] |
Zhang Y, Zhang X, Zhang J, et al. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay[J]. Cancer Biol Ther, 2016, 17(11): 1177-1187.
|
[13] |
Wu T, Dai Y. Tumor microenvironment and therapeutic response[J]. Cancer Lett, 2017, 387: 61-68.
|